What is 4D Molecular Therapeutics's change in AP?

4D Molecular Therapeutics (FDMT) reported change in AP of $3.53M in Q1 2026.

How has 4D Molecular Therapeutics's change in AP changed year-over-year?

4D Molecular Therapeutics's change in AP increased by 1603.4% year-over-year, from -$235K to $3.53M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

4D Molecular Therapeutics FDMT Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

Regeneron PharmaceuticalsREGN

$107.7M+150%

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

AbbVieABBV

-$1.59B-129%

RegenxbioRGNX

$349K+110%

MeiraGTx Holdings plcMGTX

$7.91M+358%

Other financials

Income statement

See full

Revenue$3.0M+21,664%

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

CapEx--100%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's change in AP?: 4D Molecular Therapeutics (FDMT) reported change in AP of $3.53M in Q1 2026.
How has 4D Molecular Therapeutics's change in AP changed year-over-year?: 4D Molecular Therapeutics's change in AP increased by 1603.4% year-over-year, from -$235K to $3.53M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.